Journey Medical (DERM) Non-Current Debt (2020 - 2026)

Journey Medical's Non-Current Debt history runs 7 years deep, the most recent figure standing at $22.9 million for Q1 2026.

• Quarterly Non-Current Debt fell 1.0% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.9 million (down 1.0% YoY) and the FY2025 annual result came in at $25.3 million, up 1.6% from the prior year.
• Non-Current Debt was $22.9 million for Q1 2026 at Journey Medical, down from $25.3 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $25.3 million in Q4 2025 and bottomed at $9.9 million in Q2 2023.
• A 5-year average of $19.2 million and a median of $19.8 million in 2022 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt jumped 2341.63% — and 2024, when it slumped 35.72%.
• Journey Medical's Non-Current Debt stood at $19.8 million in 2022, then decreased by 26.25% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then advanced by 1.6% to $25.3 million in 2025, then retreated by 9.51% to $22.9 million in 2026.
• Business Quant data shows DERM's Non-Current Debt at $22.9 million in Q1 2026, $25.3 million in Q4 2025, and $19.5 million in Q3 2025.